In a Healio Video Perspective from the Euretina congress, Dr. Jordi Monés discusses an investigational optogenetic therapy for geographic atrophy. This therapy utilizes laser-activated nanoparticles of gold to target the area of atrophy in the retina. This new ambient light-activated therapy developed by Nanoscope Therapeutics shows promise for the treatment of advanced geographic atrophy (GA). Monés believes that this optogenetic therapy will soon be in clinical trials, providing another treatment option for late-stage GA patients. Retina specialists have been involved in many revolutions, and optogenetics is believed to be the next breakthrough in the field.
Source link
Optogenetic therapy holds promise for treatment of late-stage geographic atrophy
